ISB News

Promotion: Dr. Jie Luo Becomes Senior Research Scientist

Congratulations to Dr. Jie Luo, of the Ranish Lab, who has been promoted to senior research scientist. From Dr. Jeff Ranish:

Jie Luo is an extremely dedicated and talented scientist. When he joined ISB in 2006 as a postdoctoral fellow, he had no experience in mass spectrometry-based proteomics. Now he is a leader in the field of structural and functional proteomics. He has conceptualized and implemented several innovative proteomics strategies for studying protein-protein interactions (PPIs) in macromolecular assemblies, and he is currently developing technology to study PPIs on a large scale.  Jie is also quite interactive, collaborating with researchers throughout the world to study the architecture of macromolecular assemblies. A good example of his work can be seen in his recent paper on the architecture of the general transcription and DNA repair factor TFIIH (Luo, et al., Molecular Cell, 2015).

Jie excels at pushing the boundaries of system biology research, and he does it while maintaining a positive attitude. Jie is valuable asset to ISB and it is a pleasure to work with him.

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.